{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:39Z","timestamp":1791318339943,"version":"4.3.1"},"reference-count":36,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the current study, we examined whether ligation of CB2 receptors would lead to induction of apoptosis in tumors of immune origin and whether CB2 agonist could be used to treat such cancers. Exposure of murine tumors EL-4, LSA, and P815 to delta-9-tetrahydrocannabinol (THC) in vitro led to a significant reduction in cell viability and an increase in apoptosis. Exposure of EL-4 tumor cells to the synthetic cannabinoid HU-210 and the endogenous cannabinoid anandamide led to significant induction of apoptosis, whereas exposure to WIN55212 was not effective. Treatment of EL-4 tumor-bearing mice with THC in vivo led to a significant reduction in tumor load, increase in tumor-cell apoptosis, and increase in survival of tumor-bearing mice. Examination of a number of human leukemia and lymphoma cell lines, including Jurkat, Molt-4, and Sup-T1, revealed that they expressed CB2 receptors but not CB1. These human tumor cells were also susceptible to apoptosis induced by THC, HU-210, anandamide, and the CB2-selective agonist JWH-015. This effect was mediated at least in part through the CB2 receptors because pretreatment with the CB2 antagonist SR144528 partially reversed the THC-induced apoptosis. Culture of primary acute lymphoblastic leukemia cells with THC in vitro reduced cell viability and induced apoptosis. Together, the current data demonstrate that CB2 cannabinoid receptors expressed on malignancies of the immune system may serve as potential targets for the induction of apoptosis. Also, because CB2 agonists lack psychotropic effects, they may serve as novel anticancer agents to selectively target and kill tumors of immune origin.<\/jats:p>","DOI":"10.1182\/blood-2002-01-0098","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"627-634","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":216,"title":["Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease"],"prefix":"10.1182","volume":"100","author":[{"given":"Robert J.","family":"McKallip","sequence":"first","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lombard","sequence":"additional","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fisher","sequence":"additional","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy R.","family":"Martin","sequence":"additional","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongho","family":"Ryu","sequence":"additional","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grant","sequence":"additional","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash S.","family":"Nagarkatti","sequence":"additional","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitzi","family":"Nagarkatti","sequence":"additional","affiliation":[{"name":"From the Departments of Microbiology and Immunology, Pharmacology and Toxicology, and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021217561879500_B1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0009-3084(00)00195-X","article-title":"Cannabinoid receptors and the regulation of immune response.","volume":"108","author":"Berdyshev","year":"2000","journal-title":"Chem Phys Lipids."},{"key":"2020021217561879500_B2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archpsyc.57.6.547","article-title":"Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report.","volume":"57","author":"Watson","year":"2000","journal-title":"Arch Gen Psychiatry."},{"key":"2020021217561879500_B3","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain.","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol."},{"key":"2020021217561879500_B4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids.","volume":"365","author":"Munro","year":"1993","journal-title":"Nature."},{"key":"2020021217561879500_B5","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor.","volume":"258","author":"Devane","year":"1992","journal-title":"Science."},{"key":"2020021217561879500_B6","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1073\/pnas.90.16.7656","article-title":"Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.","volume":"90","author":"Felder","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217561879500_B7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol."},{"key":"2020021217561879500_B8","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.95.14.8375","article-title":"The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.","volume":"95","author":"De Petrocellis","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217561879500_B9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(98)01085-0","article-title":"Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.","volume":"436","author":"Sanchez","year":"1998","journal-title":"FEBS Lett."},{"key":"2020021217561879500_B10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0014-5793(99)01073-X","article-title":"Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.","volume":"458","author":"Ruiz","year":"1999","journal-title":"FEBS Lett."},{"key":"2020021217561879500_B11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0028-3908(00)00210-0","article-title":"Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation.","volume":"40","author":"Campbell","year":"2001","journal-title":"Neuropharmacology."},{"key":"2020021217561879500_B12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/73171","article-title":"Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.","volume":"6","author":"Galve-Roperh","year":"2000","journal-title":"Nat Med."},{"key":"2020021217561879500_B13","first-page":"5784","article-title":"Inhibition of glioma growth in vivo by selective activation of the cb(2) cannabinoid receptor.","volume":"61","author":"Sanchez","year":"2001","journal-title":"Cancer Res."},{"key":"2020021217561879500_B14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/taap.1996.8049","article-title":"Evidence for the induction of apoptosis in thymocytes by 2,3,7,8- tetrachlorodibenzo-p-dioxin in vivo.","volume":"142","author":"Kamath","year":"1997","journal-title":"Toxicol Appl Pharmacol."},{"key":"2020021217561879500_B15","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.4049\/jimmunol.166.10.5889","article-title":"CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.","volume":"166","author":"Chen","year":"2001","journal-title":"J Immunol."},{"key":"2020021217561879500_B16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4615-2980-4_13","article-title":"Serum proteins affect the inhibition by delta-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse macrophages.","volume":"335","author":"Zheng","year":"1993","journal-title":"Adv Exp Med Biol."},{"key":"2020021217561879500_B17","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0006-2952(00)00492-5","article-title":"Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability.","volume":"60","author":"Jacobsson","year":"2000","journal-title":"Biochem Pharmacol."},{"key":"2020021217561879500_B18","doi-asserted-by":"crossref","first-page":"31938","DOI":"10.1074\/jbc.M005722200","article-title":"Anandamide induces apoptosis in human cells via vanilloid receptors: evidence for a protective role of cannabinoid receptors.","volume":"275","author":"Maccarrone","year":"2000","journal-title":"J Biol Chem."},{"key":"2020021217561879500_B19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(00)01425-3","article-title":"Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3.","volume":"472","author":"Sarker","year":"2000","journal-title":"FEBS Lett."},{"key":"2020021217561879500_B20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","article-title":"Pharmacology of cannabinoid receptor ligands.","volume":"6","author":"Pertwee","year":"1999","journal-title":"Curr Med Chem."},{"key":"2020021217561879500_B21","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)01160-6","article-title":"SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.","volume":"334","author":"Landsman","year":"1997","journal-title":"Eur J Pharmacol."},{"key":"2020021217561879500_B22","first-page":"582","article-title":"SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.","volume":"288","author":"Portier","year":"1999","journal-title":"J Pharmacol Exp Ther."},{"key":"2020021217561879500_B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1373.2000.22501.x","article-title":"The cannabinoid system and cytokine network.","volume":"225","author":"Klein","year":"2000","journal-title":"Proc Soc Exp Biol Med."},{"key":"2020021217561879500_B24","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0006-2952(97)82441-0","article-title":"Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.","volume":"53","author":"Koh","year":"1997","journal-title":"Biochem Pharmacol."},{"key":"2020021217561879500_B25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/taap.1996.8034","article-title":"Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.","volume":"142","author":"Schatz","year":"1997","journal-title":"Toxicol Appl Pharmacol."},{"key":"2020021217561879500_B26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0006-2952(97)00630-8","article-title":"Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.","volume":"55","author":"Herring","year":"1998","journal-title":"Biochem Pharmacol."},{"key":"2020021217561879500_B27","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1128\/MCB.10.12.6325","article-title":"Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation.","volume":"10","author":"Novak","year":"1990","journal-title":"Mol Cell Biol."},{"key":"2020021217561879500_B28","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/353858a0","article-title":"Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.","volume":"353","author":"Lenardo","year":"1991","journal-title":"Nature."},{"key":"2020021217561879500_B29","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1073\/pnas.90.6.2189","article-title":"Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.","volume":"90","author":"Deng","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217561879500_B30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.182.3.699","article-title":"Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion.","volume":"182","author":"Zhang","year":"1995","journal-title":"J Exp Med."},{"key":"2020021217561879500_B31","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1073\/pnas.91.16.7638","article-title":"Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells.","volume":"91","author":"Nagarkatti","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217561879500_B32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V89.2.610","article-title":"Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin.","volume":"89","author":"Hassuneh","year":"1997","journal-title":"Blood."},{"key":"2020021217561879500_B33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors.","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol Ther."},{"key":"2020021217561879500_B34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0167-5699(98)01300-0","article-title":"Cannabinoid receptors and immunity.","volume":"19","author":"Klein","year":"1998","journal-title":"Immunol Today."},{"key":"2020021217561879500_B35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/faat.1996.0048","article-title":"Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice.","volume":"30","author":"Chan","year":"1996","journal-title":"Fundam Appl Toxicol."},{"key":"2020021217561879500_B36","first-page":"2564","article-title":"The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.","volume":"57","author":"Iezzi","year":"1997","journal-title":"Cancer Res."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/2\/627\/1684292\/h81402000627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/2\/627\/1684292\/h81402000627.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:21:36Z","timestamp":1682324496000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/2\/627\/89135\/Targeting-CB2-cannabinoid-receptors-as-a-novel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,15]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-01-0098","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7,15]]}}}